IL27 and acute respiratory distress syndrome: In our LPS-induced ARDS in vivo model, IL-27 ASC showed superior therapeutic outcomes, with lower lung injury scores, fewer infiltrating cells, decreased total protein concentrations, and reduced pro-inflammatory cytokine gene expression compared to other treatment groups.